TDC
AGN.PRA

Thompson Davis & Co’s Allergan plc AGN.PRA Stock Holding History

Thompson Davis & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-8
Closed -$6K – 1228
2017
Q3 		$6K Hold
8
– – 0.01% 836
2017
Q2 		$7K Hold
8
– – 0.01% 784
2017
Q1 		$7K Hold
8
– – 0.01% 832
2016
Q4 		$6K Hold
8
– – 0.01% 837
2016
Q3 		$7K Hold
8
– – 0.01% 770
2016
Q2 		$7K Buy
8
+3
+60% +$2.51K 0.01% 739
2016
Q1 		$5K Hold
5
– – 0.01% 814
2015
Q4 		$5K Buy
5
+2
+67% +$2.01K 0.01% 853
2015
Q3 		$3K Buy
3
+1
+50% +$1.04K ﹤0.01% 987
2015
Q2 		$2K Buy
+2
New +$2.09K ﹤0.01% 1115

Other funds holding AGN.PRA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $112B AUM 36.28% 1-Year Est. Return
WAM
Weiss Asset Management Boston, Massachusetts $9.54B AUM 55.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $30.1B AUM 30.03% 1-Year Est. Return
ES
Equitec Specialists Chicago, Illinois $708K AUM 25.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Thompson Davis & Co's AGN.PRA Position: Q4 2017 in Review

Thompson Davis & Co sold out of Allergan plc (AGN.PRA) in Q4 2017, closing a stake of 8 shares — an estimated $6K sold.

Thompson Davis & Co first reported a position in AGN.PRA in Q2 2015 and held it in 10 quarters. The position peaked at $7K in Q2 2017. 90 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2017.

  • Thompson Davis & Co reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Thompson Davis & Co sold 8 Allergan plc shares in Q4 2017, an estimated $6K.
  • Thompson Davis & Co first reported a position in Allergan plc in Q2 2015 and held it in 10 quarters.
  • Thompson Davis & Co's Allergan plc position peaked at $7K in Q2 2017.
  • 90 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.